Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy

Chimeric antigen receptor (CAR) engineering of natural killer (NK) cells is an attractive research field in tumor immunotherapy. While CAR is genetically engineered to express certain molecules, it retains the intrinsic ability to recognize tumor cells through its own receptors. Additionally, NK cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kangdi, Zhao, Yuze, Sun, Guanqun, Zhang, Xu, Cao, Jinjin, Shao, Mingcong, Liang, Xijun, Wang, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892943/
https://www.ncbi.nlm.nih.gov/pubmed/36741400
http://dx.doi.org/10.3389/fimmu.2022.1081546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892943/
https://www.ncbi.nlm.nih.gov/pubmed/36741400
http://dx.doi.org/10.3389/fimmu.2022.1081546

Ejemplares similares